Have you ever received a blood test result showing a white blood cell count below the normal range and found yourself uncertain about what that actually means — whether it represents something serious, something temporary, something that requires immediate intervention, or something that can be monitored and managed without alarm? A low white blood cell count — the condition called ‘leukopenia’ — is one of the most common abnormal findings in routine blood work, and yet the range of conditions that can produce it is so broad and the significance of the finding so dependent on context that the result alone tells relatively little without the clinical interpretation that only a qualified healthcare provider can offer. This blog examines the 5 most common reasons for a low white blood cell count — what leukopenia is, why it occurs, and what the most common underlying causes are.
Critical medical disclaimer: This blog is written for informational and educational purposes only and does not constitute medical advice. A low white blood cell count requires evaluation by a qualified healthcare provider who can assess the finding in the context of your complete clinical picture. Do not attempt to self-diagnose or self-treat based on this information. If you have concerns about your blood test results, contact your doctor.
Table of Contents
Understanding Leukopenia — What the Numbers Mean
Leukopenia means your white blood cell count is below normal, around 4,000 cells per microlitre, which raises your infection risk. You may not notice it until infection symptoms start.
Leukopenia is classified by severity: mild at 3,000 to 4,000 cells per microlitre, moderate at 1,500 to 3,000 cells per microlitre, and severe below 1,500 cells per microlitre.
Understanding which specific type of white blood cell is low matters as much as the overall count. There are five types of white blood cells. Neutrophils account for 55 to 70% of all white blood cells. A neutrophil deficiency is known as neutropenia. Many people use the terms ‘neutropenia’ and ‘leukopenia’ interchangeably.
The practical consequence of leukopenia is straightforward — a low WBC count does not automatically mean your immune system is permanently failing, but it does mean your body may be more vulnerable to infection — and that deserves attention. Some causes are minor and reversible. Others can be life-threatening if left untreated.
Diagnosis usually starts with a complete blood count, often repeated and paired with a differential to identify which white blood cell is low. Treatment focuses on the cause and infection control, plus careful food safety and hand hygiene to lower infection risk.
1. Viral and Bacterial Infections
The most common cause of a low white blood cell count — particularly when the finding is unexpected and temporary — is infection itself, which may seem paradoxical until the underlying mechanisms are understood.
Infection is the most common cause of neutropenia in adults. Viruses can affect your bone marrow and cause low WBCs for a while. Severe infections such as blood infections can cause your body to use up WBCs faster than it can make them.
Viral infections are a common cause of transient leukopenia, including influenza, HIV, hepatitis, Epstein-Barr virus, cytomegalovirus, and COVID-19. Bacterial infections – particularly overwhelming infections including typhoid fever, tuberculosis, brucellosis, and severe sepsis – can cause leukopenia through consumption.
The specific mechanisms through which infection produces leukopenia are multiple and important to understand. Viruses can directly infect and suppress bone marrow function – the production facility for all blood cells, including white blood cells – reducing the output of new white cells at precisely the moment when demand is highest. Simultaneously, the accelerated deployment of white blood cells to sites of infection depletes the circulating pool faster than the suppressed bone marrow can replenish it.
Influenza A infection transiently suppresses bone marrow output, producing leukopenia in 8 to 27% of cases with associated lymphopenia. Severe disease shows markedly low counts and high mortality. The combination of fever plus leukopenia suggests a severe bacterial infection.
COVID-19 deserves specific mention as a cause of leukopenia that has been extensively documented. Common causes of leukopenia include infections like HIV and COVID-19. The leukopenia associated with COVID-19 is typically temporary, resolving as the infection resolves, but its presence during acute illness is associated with more severe disease.
The key clinical point about infection-related leukopenia is that it is almost always temporary — the white blood cell count recovers as the infection resolves. However, a very low white blood cell count during an acute infection represents a period of increased vulnerability to secondary infections that requires clinical monitoring.
2. Medications — Chemotherapy and Other Drugs
Leukopenia is most commonly caused by medications, infections, cancer treatments, and bone marrow disorders, with neutropenia being the predominant type of white blood cell deficiency responsible for most clinical consequences.
Medicines are the next most common cause after infections. Chemotherapy drugs in particular will destroy healthy WBCs while killing off cancer cells.
Chemotherapy and myelosuppressive drugs represent the most common medication-related cause of leukopenia through direct bone marrow suppression, affecting granulocyte production. Cytotoxic chemotherapy agents cause transient reductions in blood cells due to delayed recovery of normal blood formation, with the depth of leukopenia correlating with drug dose and timing.
Beyond chemotherapy, a range of other medications can cause leukopenia through several distinct mechanisms. Other medications that can cause leukopenia include antipsychotics — particularly clozapine — antithyroid drugs, immunosuppressants, anticonvulsants, and certain NSAIDs. Antibiotics – particularly trimethoprim/sulfamethoxazole – can cause agranulocytosis, aplastic anaemia, and leukopenia.
Thiopurine therapy — azathioprine and 6-mercaptopurine — in inflammatory bowel disease patients precipitates leukopenia in 3.2% of cases, often compounded by concurrent nutritional deficiencies. Methotrexate and other immunosuppressive therapies used in autoimmune conditions also contribute to blood abnormalities.
The clinical management of medication-induced leukopenia depends on the specific medication and the indication for its use. For chemotherapy-induced leukopenia, the standard approach includes growth factor support — medications that stimulate the bone marrow to produce more neutrophils — and infection precautions during the period of maximum count depression. For other medication-induced leukopenia, dose adjustment or alternative medication selection may be considered depending on the clinical context.
The important message for patients taking any medication associated with leukopenia risk is that regular blood monitoring — the CBC testing that allows early detection of count depression before it becomes clinically dangerous — is a critical component of safe medication management.
3. Bone Marrow Disorders and Haematological Conditions
The bone marrow is the production facility for all blood cells — red blood cells, white blood cells, and platelets are all produced from stem cells in the bone marrow in a process called ‘haematopoiesis’. When the bone marrow itself is disordered — either through intrinsic disease or through infiltration by abnormal cells — the production of white blood cells is impaired, producing leukopenia that is persistent rather than temporary.
Bone marrow disorders, including multiple myeloma and aplastic anaemia, are examples of conditions that cause leukopenia.
Myelodysplastic syndromes cause ineffective blood formation with stable reduction in blood cells lasting six or more months. Myelodysplastic syndromes are a group of clonal bone marrow disorders in which the bone marrow produces abnormal precursor cells that fail to develop into functional mature blood cells — resulting in the simultaneous reduction of red blood cells, white blood cells, and platelets that characterises the conditions.
Cancers affecting the bone marrow — including leukaemias, lymphomas, and multiple myeloma — can also cause leukopenia through direct bone marrow involvement. In these conditions, the bone marrow space normally occupied by healthy blood-forming cells is progressively replaced by malignant cells whose proliferation crowds out normal haematopoiesis.
Aplastic anaemia — the condition in which the bone marrow fails to produce adequate numbers of any blood cell type — represents the most severe form of bone marrow production failure. It can result from an autoimmune attack on bone marrow stem cells, from toxic exposures, from viral infections including hepatitis, or from genetic conditions — and it requires specific haematological management, including immunosuppression or bone marrow transplantation in severe cases.
Hypersplenism — an enlarged spleen that traps and destroys blood cells, including leukocytes — can also lead to leukopenia. This can occur in conditions like liver disease, portal hypertension, and certain haematological disorders.
4. Autoimmune Diseases
Autoimmune diseases — conditions in which the immune system mistakenly attacks the body’s own tissues — represent a significant and clinically important category of leukopenia causes, operating through mechanisms that are distinct from both infection-related and medication-related leukopenia.
Autoimmune diseases happen when your immune system attacks your body. Lupus and rheumatoid arthritis are examples of autoimmune diseases that can cause leukopenia.
Autoimmune neutropenia involves the body’s immune system mistakenly producing antibodies that target and destroy neutrophils, leading to neutropenia that often contributes to overall leukopenia. Drug-induced immune destruction can also occur when certain medications trigger an immune response that leads to the destruction of white blood cells.
Systemic lupus erythematosus — commonly called lupus or SLE — is one of the most frequently encountered autoimmune causes of leukopenia. The condition produces autoantibodies — antibodies directed against the body’s own cells and cellular components — including antibodies against white blood cells that accelerate their destruction. Leukopenia in lupus is sufficiently common that it is included among the classification criteria for the diagnosis – its presence helps establish the diagnosis in the appropriate clinical context.
Rheumatoid arthritis produces leukopenia through multiple mechanisms — the direct autoimmune activity of the disease; the medications used to treat it, including methotrexate and other disease-modifying agents; and, in some cases, Felty’s syndrome — the triad of rheumatoid arthritis, splenomegaly, and neutropenia that represents a specific complication of long-standing rheumatoid disease.
Granulomatosis with polyangiitis — a condition that causes inflammation of the blood vessels — is another autoimmune condition associated with leukopenia.
The management of autoimmune leukopenia is directed at the underlying autoimmune condition — the treatment that controls the autoimmune disease typically also improves the leukopenia, though this must be balanced against the leukopenia-inducing effects of some immunosuppressive medications used to treat these conditions.
5. Nutritional Deficiencies
The final major category of leukopenia causes is nutritional — the deficiency of specific micronutrients required for the bone marrow’s production of white blood cells. This is one of the most readily reversible causes of leukopenia — correction of the deficiency typically restores normal white blood cell production within weeks.
Vitamin B12, folate, or copper deficiencies can also lower white blood cell counts.
If a nutritional deficiency is the cause, correcting it can significantly improve WBC levels.
Vitamin B12 and folate are essential for DNA synthesis – the process required for all rapidly dividing cells, including the bone marrow precursors that become white blood cells. When either is deficient, the bone marrow’s ability to produce normal, mature white blood cells is impaired — producing a characteristic pattern of blood cell abnormalities, including leukopenia, anaemia, and, in some cases, thrombocytopenia.
Vitamin B12 deficiency is particularly common in specific populations — strict vegans and vegetarians whose diets exclude the primary dietary sources of B12 (animal products), older adults whose gastric acid production declines with age (reducing B12 absorption), patients with pernicious anaemia (an autoimmune condition that destroys the gastric cells producing intrinsic factor required for B12 absorption), and patients who have undergone gastric surgery.
Folate deficiency is most commonly associated with inadequate dietary intake — folate is found in leafy green vegetables, legumes, and fortified foods — and is particularly significant in pregnancy, where folate requirements are substantially elevated and deficiency carries specific risks for foetal neural tube development beyond its haematological effects.
Copper deficiency — less commonly recognised as a cause of leukopenia but well-documented — can occur in patients who have undergone gastric bypass surgery, in those receiving total parenteral nutrition without adequate copper supplementation, or in those with excess zinc intake, which interferes with copper absorption.
Understanding the Clinical Approach to Leukopenia
When a low white blood cell count is identified, the clinical approach to determining its cause follows a systematic pathway that begins with confirming the finding and characterising it more precisely.
A complete blood count with differential is essential to characterise the specific white blood cell lineage affected and identify other blood cell reductions. A manual differential count should be obtained to calculate absolute neutrophil count and assess for abnormal cell forms. Peripheral blood smear review is necessary to assess for abnormal cells and morphology.
The history and clinical context provide critical guidance — medications being taken, recent illnesses, symptoms of autoimmune disease, dietary history, and family history of haematological conditions all contribute to the differential diagnosis. Physical examination — particularly for lymphadenopathy, splenomegaly, and the signs of autoimmune disease — adds further diagnostic information.
The distinction between acute, temporary leukopenia — as in viral infections — and persistent leukopenia that requires further investigation is one of the most clinically important judgements in managing this finding. A white blood cell count that returns to normal on repeat testing after a recent viral illness requires no further investigation in most cases. A persistently low count, a count that is very severely depressed, or a count accompanied by other abnormal findings requires the more thorough evaluation that haematology specialists can provide.
Key Takeaways
Leukopenia ranges from mild and temporary to serious and chronic. Viral infections are the most common cause. Bone marrow disorders, autoimmune diseases, medications, and vitamin deficiencies are other major causes. Fever in someone with leukopenia can be dangerous. Treatment depends entirely on the root cause. Early evaluation improves outcomes.
The five categories examined in this blog — infections, medications, bone marrow disorders, autoimmune diseases, and nutritional deficiencies — encompass the vast majority of leukopenia causes encountered in clinical practice. Understanding which category is most likely in any individual case requires the clinical context, the examination findings, and the additional laboratory investigations that only a qualified healthcare provider can assemble and interpret.
The most important message for anyone who has received a low white blood cell count result is that the finding requires professional evaluation — not necessarily urgent alarm, but the thoughtful clinical assessment that determines whether the cause is benign and temporary or requires specific investigation and treatment.
A low white blood cell count is your immune system’s way of asking for attention. Listen to it – not with panic, but with the prompt engagement of professional medical evaluation that allows the cause to be identified and the appropriate response to be initiated.
